Table 1 Age distribution and HR-HPV infection prevalence of study subjects
Variables | Transient HR-HPV infection (n = 103) | Persistent HR-HPV Infection (n = 166) | P1 | Single HR-HPV infection (n = 160) | Multiple HR-HPV infection (n = 109) | P2 |
|---|---|---|---|---|---|---|
Age (years) | Â | Â | Â | Â | Â | Â |
 Mean ± SD | 41.55 ± 8.65 | 46.89 ± 9.72 |  < 0.001 | 43.64 ± 8.25 | 46.62 ± 11.02 | 0.018 |
 18–29 | 12 (11.7) | 14 (8.4) |  | 12 (7.5) | 14 (12.8) |  |
 30–39 | 27 (26.2) | 20 (12.0) |  | 33 (20.6) | 14 (12.8) |  |
 40–49 | 48 (46.6) | 66 (39.8) |  | 79 (49.4) | 32 (29.4) |  |
 ≥ 50 | 16 (15.5) | 66 (39.7) |  < 0.001 | 36 (22.5) | 49 (45.0) |  < 0.001 |
HR-HPV genotypes | Â | Â | Â | Â | Â | Â |
 HPV16 | 13 (12.6) | 11 (6.6) |  | 21 (13.1) | 28 (25.7) |  |
 HPV18 | 5 (4.9) | 9 (5.4) |  | 12 (7.5) | 12 (11.0) |  |
 HPV52 | 16 (15.5) | 60 (36.2) |  | 51 (31.9) | 50 (45.9) |  |
 HPV58 | 9 (8.7) | 31 (18.7) |  | 17 (10.6) | 47 (43.1) |  |
 HPV68 | 4 (3.9) | 3 (1.9) |  | 3 (1.9) | 24 (22.0) |  |
 HPV66 | 5 (4.9) | 5 (3.1) |  | 8 (5.0) | 17 (15.6) |  |
 HPV56 | 4 (3.9) | 3 (1.9) |  | 4 (2.5) | 17 (15.6) |  |
 HPV31 | 5 (4.9) | 3 (1.9) |  | 7 (4.3) | 7 (6.4) |  |
 HPV33 | 2 (1.9) | 4 (2.4) |  | 4 (2.5) | 6 (5.5) |  |
 HPV35 | 2 (1.9) | 2 (1.2) |  | 3 (1.9) | 5 (4.6) |  |
 HPV45 | 8 (7.8) | 5 (3.1) |  | 3 (1.9) | 2 (1.8) |  |
 HPV82 | 2 (1.9) | 1 (0.1) |  | 0 | 1 (0.1) |  |
 HPV39 | 0 | 0 |  | 9 (5.6) | 11 (10.1) |  |
 HPV51 | 12 (11.7) | 7 (4.2) |  | 15 (9.4) | 12 (11.0) |  |
 HPV59 | 2 (1.9) | 8 (4.8) |  | 3 (1.9) | 15 (13.8) |  |
 Multiple genotypes | 14 (13.6) | 14 (8.5) |  | NA | NA |  |